Haemonetics - 34 Year Stock Price History | HAE
Historical daily share price chart and data for Haemonetics since 1991 adjusted for splits and dividends. The latest closing stock price for Haemonetics as of April 21, 2025 is 57.00.
- The all-time high Haemonetics stock closing price was 139.48 on February 08, 2021.
- The Haemonetics 52-week high stock price is 97.97, which is 71.9% above the current share price.
- The Haemonetics 52-week low stock price is 55.30, which is 3% below the current share price.
- The average Haemonetics stock price for the last 52 weeks is 77.94.
| Haemonetics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 66.4192 | 78.4000 | 80.0500 | 56.0400 | 57.0000 | -27.00% |
| 2024 | 81.9057 | 85.1400 | 97.3700 | 71.1600 | 78.0800 | -8.69% |
| 2023 | 85.3291 | 77.1800 | 93.4900 | 72.7500 | 85.5100 | 8.72% |
| 2022 | 66.5324 | 54.7000 | 86.1400 | 43.7700 | 78.6500 | 48.28% |
| 2021 | 79.1445 | 119.0700 | 139.4800 | 49.5500 | 53.0400 | -55.33% |
| 2020 | 101.0665 | 115.2700 | 121.8200 | 74.3400 | 118.7500 | 3.35% |
| 2019 | 109.5751 | 97.3000 | 138.5200 | 81.7400 | 114.9000 | 14.84% |
| 2018 | 90.5582 | 63.1000 | 116.6300 | 60.7200 | 100.0500 | 72.26% |
| 2017 | 43.6001 | 39.6000 | 58.9900 | 36.9000 | 58.0800 | 44.48% |
| 2016 | 33.6385 | 31.2500 | 41.0400 | 26.1300 | 40.2000 | 24.69% |
| 2015 | 38.4527 | 36.9200 | 45.3800 | 30.8500 | 32.2400 | -13.84% |
| 2014 | 35.9682 | 41.2800 | 43.3700 | 30.3600 | 37.4200 | -11.18% |
| 2013 | 41.3454 | 42.1300 | 45.8100 | 37.7500 | 42.1300 | 3.16% |
| 2012 | 36.4214 | 31.3900 | 41.3800 | 30.9250 | 40.8400 | 33.42% |
| 2011 | 31.0868 | 30.1400 | 35.1000 | 27.5050 | 30.6100 | -3.10% |
| 2010 | 28.1781 | 27.7150 | 32.1900 | 25.6200 | 31.5900 | 14.56% |
| 2009 | 27.4174 | 28.0050 | 32.3250 | 24.4250 | 27.5750 | -2.39% |
| 2008 | 28.8424 | 30.9200 | 32.7100 | 24.7950 | 28.2500 | -10.35% |
| 2007 | 25.2441 | 22.6900 | 31.5100 | 21.7500 | 31.5100 | 39.98% |
| 2006 | 24.0373 | 24.4000 | 27.4500 | 20.5450 | 22.5100 | -7.86% |
| 2005 | 21.6157 | 18.4000 | 26.3950 | 17.0800 | 24.4300 | 34.94% |
| 2004 | 15.1271 | 11.9700 | 18.4950 | 11.8700 | 18.1050 | 51.57% |
| 2003 | 10.5768 | 11.0000 | 12.2350 | 8.2400 | 11.9450 | 11.32% |
| 2002 | 13.6927 | 16.8400 | 17.1750 | 9.3500 | 10.7300 | -36.73% |
| 2001 | 16.3680 | 14.8438 | 20.8500 | 13.7000 | 16.9600 | 9.86% |
| 2000 | 11.9002 | 11.7813 | 15.4375 | 9.9375 | 15.4375 | 29.66% |
| 1999 | 9.4024 | 11.3438 | 12.0313 | 6.9063 | 11.9063 | 4.67% |
| 1998 | 8.7488 | 7.1563 | 11.4063 | 6.7500 | 11.3750 | 62.50% |
| 1997 | 8.5821 | 9.3750 | 10.5313 | 6.9063 | 7.0000 | -25.83% |
| 1996 | 9.1806 | 8.8750 | 10.8125 | 8.1875 | 9.4375 | 6.34% |
| 1995 | 9.0680 | 8.6250 | 11.5000 | 6.5625 | 8.8750 | 2.90% |
| 1994 | 9.6399 | 13.5000 | 13.6875 | 7.2500 | 8.6250 | -37.84% |
| 1993 | 11.7901 | 12.4688 | 14.1250 | 8.3750 | 13.8750 | 5.97% |
| 1992 | 8.4563 | 9.0938 | 13.0938 | 6.1875 | 13.0938 | 38.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.872B | $1.309B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |